The application of microspheres from the copolymers of lactide and epsilon-caprolactone to the controlled release of steroids.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Controlled Release

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  PMID 9801439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of processing parameters on the properties of peptide-containing PLGA microspheres.

  1997cited by this paper
• Estrogen Therapy for Postmenopausal Symptoms and Prevention of Osteoporosis

  1995cited by this paper
• Gamma Irradiation Effects on Molecular Weight and in Vitro Degradation of Poly(D,L-Lactide-CO-Glycolide) Microparticles

  1995cited by this paper
• Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres.

  1995cited by this paper
• Controlled release of beta-estradiol from biodegradable microparticles within a silicone matrix.

  1994cited by this paper
• In Vivo Evaluation of Biodegradable Progesterone Microspheres in Mares

  1992cited by this paper
• A physicochemical study of the morphology of progesterone-loaded microspheres fabricated from poly(D,L-lactide-co-glycolide).

  1991cited by this paper
• Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women.

  1991cited by this paper
• The Preparation and Evaluation of Drug-Containing Poly(dl-lactide) Microspheres Formed by the Solvent Evaporation Method

  1987cited by this paper
• Poly(lactide-co-glycolide) microcapsules for controlled release of steroids.

  1985cited by this paper
• Characterization of drug-loaded poly(d,l-lactide) microspheres.

  1984cited by this paper
• Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo.

  1981cited by this paper
• A new long-acting injectable microcapsule system for the administration of progesterone.

  1979cited by this paper

• Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications: An Overview of Recent Advances

  2022cites this paper
• Structure and interaction roles in the release profile of chalcone-loaded liposomes.

  2022cites this paper
• PLAGA-PEG-PLAGA Terpolymer-Based Carriers of Herbicides for Potential Application in Environment-Friendly, Controlled Release Systems of Agrochemicals

  2020cites this paper
• Development of a Long-Term Drug Delivery System with Levonorgestrel-Loaded Chitosan Microspheres Embedded in Poly(vinyl alcohol) Hydrogel.

  2019cites this paper
• Long-Acting Injectable Hormonal Dosage Forms for Contraception

  2015cites this paper
• In vitro evaluation of suspoemulsions for in situ-forming polymeric microspheres and controlled release of progesterone

  2015cites this paper
• In Situ-Formed Microparticles of PLGA from O/W Emulsions Stabilized with PVA: Encapsulation and Controlled Release of Progesterone

  2014cites this paper
• Double layer paclitaxel delivery systems based on bioresorbable terpolymer with shape memory properties.

  2014cites this paper
• Influence of polymer blends on the characterization of gliclazide – encapsulated into poly (Æ-caprolactone) microparticles

  2013cites this paper
• Novel Poly(L-lactide-co-ε-caprolactone) Matrices Obtained with the Use of Zr[Acac]4 as Nontoxic Initiator for Long-Term Release of Immunosuppressive Drugs

  2013cites this paper
• Enzyme-Catalyzed Degradation of Biodegradable Polymers Derived from Trimethylene Carbonate and Glycolide by Lipases from Candida Antarctica and Hog Pancreas

  2012cites this paper
• Fabrication and Evaluation of Various Polymeric Matrices for the Formulation of Once-A-Day Controlled Release Tablets of Some Aryl-Propionic Acid Analogs

  2010cites this paper
• Inclusion mechanism of steroid drugs into beta-cyclodextrins. Insights from free energy calculations.

  2009cites this paper
• Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.

  2009cites this paper
• Controlled release of drugs from multi-component biomaterials.

  2008cites this paper
• Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.

  2008cites this paper
• Materials in particulate form for tissue engineering. 1. Basic concepts

  2007cites this paper
• Poly(epsilon-caprolactone) microparticles formed by the emulsion-evaporation method: effect of the variables of the different steps of the process on their size.

  2007cites this paper
• Solid state characterization of progesterone in a freeze dried 1:2 progesterone/HPBCD mixture.

  2007cites this paper
• Effects of block length on the enzymatic degradation and erosion of oxazoline linked poly-epsilon-caprolactone.

  2007cites this paper
• Formulating Drug Delivery Systems by Spray Drying

  2006cites this paper
• Resilient bioresorbable copolymers based on trimethylene carbonate, L-lactide, and 1,5-dioxepan-2-one.

  2006cites this paper
• Polycaprolactone-block-poly(ethylene oxide) micelles: a nanodelivery system for 17beta-estradiol.

  2005cites this paper
• Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution.

  2005cites this paper
• Biodegradable Microparticulates of Beta-Estradiol: Preparation and In Vitro Characterization

  2005cites this paper
• Microesferas biodegradables de poli(D,L-láctico) conteniendo progesterona

  2005cites this paper
• Evaluation of biodegradable synthetic scaffold coated on arterial prostheses implanted in rat subcutaneous tissue.

  2005cites this paper
• Poly-epsilon-caprolactone microspheres and nanospheres: an overview.

  2004cites this paper
• Recent developments in ring opening polymerization of lactones for biomedical applications.

  2003cites this paper
• Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.

  2003cites this paper
• Preparation of bupivacaine-loaded poly(epsilon-caprolactone) microspheres by spray drying: drug release studies and biocompatibility.

  2003cites this paper
• Therapeutic effect of in vivo sustained estradiol release from poly (lactide‐co‐glycolide) microspheres on bone mineral density of osteoporosis rats

  2002cites this paper
• Biodegradable microspheres of novel segmented poly(ether-ester-amide)s based on poly(epsilon-caprolactone) for the delivery of bioactive compounds.

  2001cites this paper
• Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone.

  2000cites this paper
• Immune Response to 17β-Estradiol Involved in Polymer Gels: Antigen Specificity and Affinity of Hybridoma Clones

  2000cites this paper
• Literature alerts.

  1999cites this paper